Status:
COMPLETED
Capturing Outcomes of Clinical Activities Performed by a Rounding Pharmacist Practising in a Team Environment
Lead Sponsor:
University of Alberta
Collaborating Sponsors:
Capital Health, Canada
Conditions:
Heart Failure, Congestive
Pulmonary Disease, Chronic Obstructive
Eligibility:
All Genders
18+ years
Phase:
PHASE4
Brief Summary
We, the researchers, propose to link a clinical pharmacist with an internal medicine or family medicine team to provide pharmaceutical care to all patients assigned to the team. The hypothesis is that...
Detailed Description
The overall goal of the COLLABORATE study is to improve processes of care and patient outcomes by optimizing drug therapy via a hospital pharmacy practice model that integrates clinical pharmacists in...
Eligibility Criteria
Inclusion
- Consecutive patients \> 18 years of age admitted to participating internal and family medicine teams during the 1 year study period will be eligible to receive the pharmacist intervention. For the purposes of data analysis, patients with a most responsible or primary diagnosis of HF, COPD, CAP, T2DM, and CAD will be included.
Exclusion
- Residence outside the Capital Health catchment
- Admitted for ≤ 2 days
- Palliative care
- Transferred to another team
Key Trial Info
Start Date :
February 1 2006
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 1 2007
Estimated Enrollment :
452 Patients enrolled
Trial Details
Trial ID
NCT00351676
Start Date
February 1 2006
End Date
July 1 2007
Last Update
December 11 2007
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
Royal Alexandra Hospital
Edmonton, Alberta, Canada, T5H 3V9
2
University of Alberta Hospital
Edmonton, Alberta, Canada, T6G 2B7
3
Grey Nuns Community Hospital
Edmonton, Alberta, Canada, T6L 5X8